Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans

Infection and Immunity

Volumn 66, Issue 9, 1998, Pages 4324-4330

  Vecchiarelli, Anna ^a   Retini, Cinzia ^a   Casadevall, Arturo ^b   Monari, Claudia ^a   Pietrella, Donatella ^d   Kozel, Thomas R ^c  

^a UNIVERSITY OF PERUGIA   (Italy)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; GLUCURONOXYLOMANNAN; INTERLEUKIN 8; MONOCLONAL ANTIBODY; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ARTICLE; COMPLEMENT ACTIVATION; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; LEUKOCYTE ACTIVATION; NONHUMAN; PASSIVE IMMUNIZATION; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN CROSS LINKING; SERUM;

EID: 0031667440     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/.66.9.4324-4330.1998     Document Type: Article

References (41)

1. Cassatella, M. A., F. Bazzoni, M. Ceska, I. Ferro, M. Baggiolini, and G. Berton. 1992. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylamine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. J. Immunol. 148:3216-3220.
2. Cherniak, R., E. Reiss, M. E. Slodki, R. D. Plattner, and S. O. Blumer. 1980. Structure and antigenic activity of the capsular polysaccharide to Cryptococcus neoformans. Mol. Immunol. 17:1025-1032.
3. Davies, S. P., D. P. Clifford, J. R. Hoidal, and J. E. Repine. 1982. Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes. J. Infect. Dis. 145:870-874.
4. Debets, J. M., J. Van Der Linder, I. E. M. Dieteren, J. F. M. Leewenberg, and W. A. Bourman. 1988. Fc receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes. J. Immunol. 4:197-201.
5. Diamond, R. D., J. E. May, M. A. Kane, M. M. Frank, and J. E. Bennett. 1974. The role of the classical and alternative complement pathways in host defenses against Cryptococcus neoformans infection. J. Immunol. 112:2260-2270.
6. Diamond, R. D., R. K. Root, and J. E. Bennett. 1972. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J. Infect. Dis. 125:367-376.
7. Dong, Z. M., and J. W. Murphy. 1996. Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. J. Clin. Invest. 97:689-698.
8. Dong, Z. M., and J. W. Murphy. 1997. Cryptococcal polysaccharides bind to CD-18 on human neutrophils. Infect. Immun. 65:557-563.
9. Dromer, F., P. Aucouturier, J.-P. Clauvel, G. Saimot, and P. Yeni. 1988. Cryptococcus neoformans antibody levels in patients with AIDS. Scand. J. Infect. Dis. 20:283-285.
10. Dromer, F., C. Perron ne, J. Barge, J. L. Vilde, and P. Yeni. 1989. Role of IgG and complement component C5 in the initial course of experimental cryptococcosis. Clin. Exp. Immunol. 78:412-417.
11. Ember, J. A., S. D. Sanderson, T. E. Hugli, and E. L. Morgan. 1994. Induction of interleukin-8 synthesis from monocytes by human C5a anaphylotoxin. Am. J. Pathol. 146:393-403.
12. Fazekas, G., and J. Schwarz. 1958. Histology of experimental murine cryptococcosis. Am. J. Pathol. 34:517-529.
13. Good, C. B., and W. A. Coax. 1990. Cryptococcal infection in patients with AIDS. N. Engl. J. Med. 322:701-702.
14. Graybill, J. R., R. Bocanegra, C. Lambros, and M. F. Luther. 1997. Granulocyte colony stimulating factor therapy of experimental Cryptococcal meningitis. J. Med. Vet. Mycol. 35:243-247.
15. Graybill, J. R., and L. Mitchell. 1978. Cyclophosphamide effects on murine cryptococcosis. Infect. Immun. 21:674-677.
16. Houpt, D. C., G. T. Pfrommer, B. J. Young, T. A. Larson, and T. R. Kozel. 1994. Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan. Infect. Immun. 62:2857-2864.
17. Keller, R. G., G. S. T. Pfrommer, and T. R. Kozel. 1994. Occurrences, specificities, and functions of ubiquitous antibodies in human serum that are reactive with the Cryptococcus neoformans cell wall. Infect. Immun. 62:215-220.
18. Kozel, T. R., and E. C. Gotschlich. 1982. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast macrophages. J. Immunol. 129:1675-1680.
19. Kozel, T. R., and R. P. Mastroianni. 1976. Inhibition of phagocytosis by Cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis. Infect. Immun. 14:62-67.
20. Kozel, T. R., M. A. Wilson, and J. W. Murphy. 1991. Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans. Infect. Immun. 59:3101-3110.
21. Kozel, T. R., M. A. Wilson, G. S. T. Pfrommer, and A. M. Schlageter. 1989. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins. Infect. Immun. 57:1922-1927.
22. Kozel, T. R., M. A. Wilson, and W. H. Welch. 1992. Kinetic analysis of the amplification phase for activation and binding of C3 to encapsulated and nonencapsulated Cryptococcus neofonnans. Infect. Immun. 60:3122-3127.
23. Kwong-Chung, K. J., and J. E. Bennett. 1992. Medical mycology, p. 397-446. Williams and Wilkins, Baltimore, Md.
24. Laxalt, K. A., and T. R. Kozel. 1979. Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neofonnans. Infect. Immun. 26:435-440.
25. Levine, S., H. M. Zimmerman, and A. Scorza. 1957. Experimental cryptococcosis (torulosis). Am. J. Pathol. 33:385-409.
26. Lipovsky, M. M., G. Gekker, S, Hu, L. C. Ehrlich, A. I. Hoepelman, and P. K. Peterson. 1998. Cryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by human microglia but inhibits neutrophil migration toward IL-8. J. Infect. Dis. 177:260-263.
27. Marsch, C. B., J. E. Gadek, G. C. Kindt, S. A. Moore, and M. D. Wewers. 1995. Monocyte Fc-γ receptor cross-linking induces IL-8 production. J. Immunol. 155:3161-3167.
28. Miller, G. P. G., and S. Kohl. 1983. Antibody-dependent leucocyte killing of Cryptococcus neoformans. J. Immunol. 131:1455-1459.
29. Miller, M. F., and T. G. Mitchell. 1991. Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect. Immun. 59:24-28.
30. Mukherjee, J., M. D. Scharff, and A. Casadevall. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60:4534-4541.
31. Mukherjee, S., S. Lee, J. Mukherjee, M. D. Scharff, and A. Casadevall. 1994. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect. Immun. 62:1079-1088.
32. Murphy, J. W., and G. C. Cozad. 1972. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect. Immun. 5:896-901.
33. Quidel. 1994. Technical bulletin, goat anti-C5. Quidcl, San Diego, Calif.
34. Retini, C., A. Vecchiarelli, C. Monari, C. Tascini, F. Bistoni, and T. R. Kozel. 1996. Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils. Infect. Immun. 64:2897-2903.
35. Tacker, J. B., F. Furhi, and G. S. Bulmer. 1972. Intracellular fate of Cryptococcus neoformans. Infect. Immun. 6:162-167.
36. Vecchiarelli, A., D. Pietrella, M. Dottorini, C. Monari, C. Retini, and T. Todisco. 1994. Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages. Clin. Exp. Immunol. 98:217-223.
37. Vecchiarelli, A., C. Retini, C. Monari, C. Tascini. F. Bistoni, and T. R. Kozel. 1996. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect. Immun. 64:2846-2849.
38. Vecchiarelli, A., C. Retini, D. Pietrella, C. Monari, C. Tascini, T. Beccari, and T. R. Kozel. 1995. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1β secretion from human monocytes. Infect. Immun. 63:2919-2923.
39. Weiss, C., I. H. Perry, and M. C. Shevky. 1948. Infection of the human eye with Cryptococcus neoformans (Torula histolytica; Cryptococcus hominis). Arch. Ophthalmol. 39:739-751.
40. Wilson, M. A., and T. R. Kozel, 1992. Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans. Infect. Immun. 60:754-761.
41. Young, B. I., and T. R. Kozel. 1993. Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans. Infect. Immun. 61:2966-2972.